Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAPK8IP3 antisense RNA 1 (MAPK8IP3-AS1, also known as LA16c-329F2.1) is a long non-coding RNA gene located antisense to the MAPK8IP3 locus. While its precise biological function has not been described in the publicly available genetic and biomedical literature, as an antisense lncRNA, MAPK8IP3-AS1 may regulate MAPK8IP3 gene expression at the RNA level, potentially through base pairing and interference with sense strand transcription or transcript stability. No evidence currently supports its role as a therapeutic target, receptor, enzyme, or direct participant in disease or drug interactions. The clinical and functional significance of MAPK8IP3-AS1 remains largely uncharacterized.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAPK8IP3 antisense RNA 1 (MAPK8IP3-AS1).